AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 173 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,431,762 | +91.1% | 312,968 | +138.0% | 0.01% | +11.1% |
| Q2 2023 | $1,272,765 | -76.0% | 131,484 | -72.8% | 0.01% | -60.9% |
| Q1 2023 | $5,293,330 | +154.5% | 482,968 | +0.3% | 0.02% | +9.5% |
| Q4 2022 | $2,080,011 | -33.3% | 481,484 | +16.1% | 0.02% | -25.0% |
| Q3 2022 | $3,118,000 | +12.2% | 414,684 | +50.0% | 0.03% | +33.3% |
| Q2 2022 | $2,779,000 | -14.1% | 276,484 | +5.7% | 0.02% | -52.3% |
| Q1 2022 | $3,237,000 | +42.1% | 261,484 | +162.5% | 0.04% | +91.3% |
| Q4 2021 | $2,278,000 | -54.2% | 99,600 | -55.7% | 0.02% | -66.2% |
| Q3 2021 | $4,979,000 | -39.5% | 225,000 | -64.6% | 0.07% | -31.3% |
| Q2 2021 | $8,230,000 | -18.2% | 635,000 | -18.1% | 0.10% | -20.2% |
| Q1 2021 | $10,063,000 | -48.0% | 775,000 | -44.6% | 0.12% | +19.2% |
| Q4 2020 | $19,362,000 | +136.8% | 1,400,000 | +152.3% | 0.10% | -14.8% |
| Q3 2020 | $8,175,000 | +34.2% | 555,000 | +48.0% | 0.12% | +14.0% |
| Q2 2020 | $6,093,000 | +2.4% | 375,000 | -8.5% | 0.11% | -28.2% |
| Q1 2020 | $5,949,000 | -16.1% | 410,000 | +17.1% | 0.15% | -5.7% |
| Q4 2019 | $7,091,000 | +232.0% | 350,000 | -12.5% | 0.16% | +167.8% |
| Q3 2019 | $2,136,000 | -45.4% | 400,000 | -32.8% | 0.06% | -34.4% |
| Q2 2019 | $3,915,000 | +46.0% | 595,000 | +44.2% | 0.09% | +157.1% |
| Q1 2019 | $2,681,000 | +42.9% | 412,500 | +50.0% | 0.04% | +40.0% |
| Q4 2018 | $1,876,000 | -17.5% | 275,000 | -19.7% | 0.02% | -10.7% |
| Q3 2018 | $2,274,000 | +75.6% | 342,500 | +48.9% | 0.03% | +55.6% |
| Q2 2018 | $1,295,000 | -16.8% | 230,000 | -23.3% | 0.02% | -43.8% |
| Q1 2018 | $1,557,000 | -23.6% | 300,000 | -33.3% | 0.03% | -27.3% |
| Q4 2017 | $2,039,000 | -13.3% | 450,000 | +20.0% | 0.04% | -24.1% |
| Q3 2017 | $2,351,000 | +9.6% | 375,000 | +7.1% | 0.06% | +34.9% |
| Q2 2017 | $2,146,000 | – | 350,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 503,248 | $6,535,000 | 10.30% |
| Prosight Management, LP | 360,834 | $4,685,000 | 3.84% |
| Healthcare Value Capital, LLC | 100,000 | $1,299,000 | 2.89% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,748,208 | $22,700,000 | 2.32% |
| DG Capital Management, LLC | 591,154 | $7,676,000 | 1.83% |
| NEA Management Company, LLC | 5,172,683 | $67,193,000 | 1.51% |
| Altium Capital Management LP | 408,908 | $5,310,000 | 1.47% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 170,316 | $2,212,000 | 1.17% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 298,500 | $3,875,000 | 1.02% |
| KNOTT DAVID M | 154,840 | $2,011,000 | 0.86% |